Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Clarifying differences in natural history between models of screening: the case of colorectal cancer.

van Ballegooijen M, Rutter CM, Knudsen AB, Zauber AG, Savarino JE, Lansdorp-Vogelaar I, Boer R, Feuer EJ, Habbema JD, Kuntz KM.

Med Decis Making. 2011 Jul-Aug;31(4):540-9. doi: 10.1177/0272989X11408915. Epub 2011 Jun 14.

2.

A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression.

Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, Feuer EJ, Zauber AG.

Med Decis Making. 2011 Jul-Aug;31(4):530-9. doi: 10.1177/0272989X11408730. Epub 2011 Jun 14.

3.

An evidence-based microsimulation model for colorectal cancer: validation and application.

Rutter CM, Savarino JE.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1992-2002. doi: 10.1158/1055-9965.EPI-09-0954. Epub 2010 Jul 20.

4.

Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.

Haug U, Knudsen AB, Lansdorp-Vogelaar I, Kuntz KM.

Int J Cancer. 2015 Jun 15;136(12):2864-74. doi: 10.1002/ijc.29343. Epub 2014 Dec 3.

5.

A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.

Ramsey SD, Wilschut J, Boer R, van Ballegooijen M.

Am J Gastroenterol. 2010 Aug;105(8):1861-9. doi: 10.1038/ajg.2010.185. Epub 2010 May 11.

PMID:
20461066
6.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
7.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
8.

Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.

Goede SL, Kuntz KM, van Ballegooijen M, Knudsen AB, Lansdorp-Vogelaar I, Tangka FK, Howard DH, Chin J, Zauber AG, Seeff LC.

Med Care. 2015 Jul;53(7):630-8. doi: 10.1097/MLR.0000000000000380.

9.
10.

The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening.

Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JD.

Comput Biomed Res. 1999 Feb;32(1):13-33.

PMID:
10066353
11.

Potential impact of population-based colorectal cancer screening in Canada.

Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E.

Chronic Dis Can. 2003 Fall;24(4):81-8.

PMID:
14733756
12.

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.

13.

[Cost-effectiveness of colorectal cancer screening].

Heresbach D, Manfrédi S, Branger B, Bretagne JF.

Gastroenterol Clin Biol. 2006 Jan;30(1):44-58. French.

14.

Endoscopic colorectal cancer screening: a cost-saving analysis.

Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD.

J Natl Cancer Inst. 2000 Apr 5;92(7):557-63.

PMID:
10749911
15.

Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

Tsoi KK, Ng SS, Leung MC, Sung JJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.

16.

Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy.

Brenner H, Altenhofen L, Stock C, Hoffmeister M.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1043-51. doi: 10.1158/1055-9965.EPI-13-0162. Epub 2013 Apr 30.

17.

A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults.

Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB.

Int J Technol Assess Health Care. 2000 Summer;16(3):799-810.

PMID:
11028135
18.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
19.

Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.

Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R.

Gut. 2012 Aug;61(8):1172-9. doi: 10.1136/gutjnl-2011-300206. Epub 2011 Oct 13.

PMID:
21997545
20.

Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies.

Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U.

Gut. 2007 Nov;56(11):1585-9. Epub 2007 Jun 25.

Supplemental Content

Support Center